iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Get Free Report) shares fell 1.3% during mid-day trading on Tuesday . The stock traded as low as $22.76 and last traded at $22.86. 48,876 shares were traded during trading, an increase of 38% from the average session volume of 35,439 shares. The stock had previously closed at $23.16.
iShares Genomics Immunology and Healthcare ETF Stock Down 1.3 %
The firm has a market cap of $133.71 million, a price-to-earnings ratio of 2.29 and a beta of 1.14. The company’s 50-day moving average price is $23.61 and its 200-day moving average price is $23.37.
About iShares Genomics Immunology and Healthcare ETF
The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.
Further Reading
- Five stocks we like better than iShares Genomics Immunology and Healthcare ETF
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- RXO Shares Surge Following New Acquisition Deal
- What does consumer price index measure?
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Dividend Capture Strategy: What You Need to Know
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for iShares Genomics Immunology and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Genomics Immunology and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
